Skip to main content
BJDX
NASDAQ Industrial Applications And Services

Bluejay Diagnostics Secures U.S. Manufacturing Partnership for Symphony™ Platform

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$2.18
Mkt Cap
$2.245M
52W Low
$1.623
52W High
$16.68
52W Position info
34% above low
Off High info
87% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

BJDX sits 34% above its 52-week low of $1.623.

Summary

Bluejay Diagnostics has partnered with Argonaut Manufacturing Services to establish U.S.-based manufacturing for its Symphony™ platform, a key move to support future commercialization and strengthen its supply chain.


Key Events · M&A and Partnerships · BJDX

  • Strategic Manufacturing Agreement

    Bluejay Diagnostics entered into a material definitive agreement with Argonaut Manufacturing Services for comprehensive manufacturing services for its Symphony™ platform, specifically IL-6 testing products.

  • U.S.-Based Production Established

    The partnership aims to establish scalable U.S.-based manufacturing capabilities, reducing reliance on overseas production and enhancing supply chain resilience.

  • Supports Commercialization Goals

    This move is critical for advancing Bluejay's clinical development programs and future commercialization objectives for its near-patient diagnostic solutions.

  • Addresses Operational Risk

    The agreement helps de-risk the company's operational foundation, which is vital given its current financial challenges and stated need for capital.


Analysis · BJDX · Industrial Applications And Services

This agreement with Argonaut Manufacturing Services is a critical step for Bluejay Diagnostics, establishing scalable U.S.-based manufacturing for its IL-6 testing products on the Symphony™ platform. For a company facing a going concern warning and needing significant capital, securing a robust domestic supply chain is essential for de-risking future commercialization efforts and potentially attracting necessary funding. It mitigates reliance on overseas manufacturing and supports ongoing clinical development.

At the time of this filing, BJDX was trading at $2.18 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.2M. The 52-week trading range was $1.62 to $16.68. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BJDX - Latest Insights

BJDX
Jun 26, 2026, 4:44 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $2.98
Real-time Price: $1.39 info
Change: -$1.59 (-53%) info
Market Cap: $1.5M info
BJDX
Jun 17, 2026, 5:20 PM EDT
Filing Type: S-3
Importance Score:
9
Price at Filing: $4.44
Real-time Price: $1.39 info
Change: -$3.05 (-69%) info
Market Cap: $1.5M info
BJDX
Jun 09, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.82
Real-time Price: $1.39 info
Change: -$3.43 (-71%) info
Market Cap: $1.5M info
BJDX
Jun 08, 2026, 5:23 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $5.00
Real-time Price: $1.39 info
Change: -$3.61 (-72%) info
Market Cap: $1.5M info
BJDX
Jun 08, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $5.01
Real-time Price: $1.39 info
Change: -$3.62 (-72%) info
Market Cap: $1.5M info
BJDX
Jun 05, 2026, 8:13 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $4.65
Real-time Price: $1.39 info
Change: -$3.26 (-70%) info
Market Cap: $1.5M info
BJDX
Jun 02, 2026, 9:00 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $4.09
Real-time Price: $1.39 info
Change: -$2.70 (-66%) info
Market Cap: $1.5M info
BJDX
Jun 02, 2026, 8:10 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $4.09
Real-time Price: $1.39 info
Change: -$2.70 (-66%) info
Market Cap: $1.5M info
BJDX
Jun 02, 2026, 12:19 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $4.63
Real-time Price: $1.39 info
Change: -$3.24 (-70%) info
Market Cap: $1.5M info
BJDX
Jun 02, 2026, 6:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.18
Real-time Price: $1.39 info
Change: -$0.790 (-36%) info
Market Cap: $1.5M info